Eagle Bay Advisors’s BeOne Medicines Ltd ONC Stock Holding History

Eagle Bay Advisors’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-24	Closed	-$4.43K	–	989
2024 Q4	$4.43K	Hold	24	–	–	﹤0.01%	733
2024 Q3	$5.39K	Hold	24	–	–	﹤0.01%	974
2024 Q2	$3.42K	Buy	24 +15	+167%	+$2.31K	﹤0.01%	795
2024 Q1	$1.41K	Hold	9	–	–	﹤0.01%	909
2023 Q4	$1.62K	Hold	9	–	–	﹤0.01%	766
2023 Q3	$1.62K	Hold	9	–	–	﹤0.01%	785
2023 Q2	$1.6K	Hold	9	–	–	﹤0.01%	779
2023 Q1	$1.94K	Hold	9	–	–	﹤0.01%	763
2022 Q4	$1.98K	Hold	9	–	–	﹤0.01%	767
2022 Q3	$1K	Hold	9	–	–	﹤0.01%	889
2022 Q2	$1.46K	Buy	+9	New	+$1.41K	﹤0.01%	866
2022 Q1	–	Sell	-9	Closed	-$2K	–	1010
2021 Q4	$2K	Buy	+9	New	+$3.04K	﹤0.01%	954

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Eagle Bay Advisors's ONC Position: Q1 2025 in Review

Eagle Bay Advisors sold out of BeOne Medicines Ltd (ONC) in Q1 2025, closing a stake of 24 shares — an estimated $4.43K sold.

Eagle Bay Advisors first reported a position in ONC in Q4 2021 and held it in 12 quarters. The position peaked at $5.39K in Q3 2024. 267 funds tracked by Wall St. Rank hold ONC as of Q1 2025.

Eagle Bay Advisors reported no remaining BeOne Medicines Ltd position as of Q1 2025 after selling out during the quarter.
Eagle Bay Advisors sold 24 BeOne Medicines Ltd shares in Q1 2025, an estimated $4.43K.
Eagle Bay Advisors first reported a position in BeOne Medicines Ltd in Q4 2021 and held it in 12 quarters.
Eagle Bay Advisors's BeOne Medicines Ltd position peaked at $5.39K in Q3 2024.
267 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2025.

Based on Eagle Bay Advisors's 13F filing for Q1 2025, filed 5 May 2025.